Able Laboratories posts $20.72 million October operating loss

By Caroline Salls

Pittsburgh, Nov. 21 - Able Laboratories Inc. reported a $20.72 million operating loss on zero revenues in October, according to its monthly operating report filed Friday with the U.S. Bankruptcy Court for the District of New Jersey.

The net loss for the month was $20.84 million.

Cash and cash equivalents on Oct. 31 were $5.98 million.

Able is a Cranbury, N.J., developer and manufacturer of general pharmaceuticals. The company filed for bankruptcy on July 11. Its Chapter 11 case number is 05-33129.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.